
Enzyme-linked immunosorbent assay intended for the quantitative and qualitative detection of IgG antibodies against the spike protein of SARS-CoV-2 in human serum (venous, capillary) or plasma (citrate, heparin, EDTA). It is intended to aid in the diagnosis of patients suspected of having COVID-19 disease or asymptomatic infection with SARS-CoV-2, to monitor antibody levels during and after a COVID-19 disease, and to determine antibody levels before and after a COVID-19 vaccination.
Disease: COVID-19
Symptoms: It can present as an asymptomatic infection, a mild respiratory tract infection, or a severe pneumonia with respiratory failure and even death. The incubation period ranges from 2-14 days (5 days on average), and symptoms can include fever, cough, and shortness of breath
Mechanism of Infection: Primarily transmitted between people through respiratory droplets and contact routes